article thumbnail

DEA finally ends fed monopoly on schwaggy research-grade cannabis

SpeedWeed

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. cannabis researchers. For years, NIDA and the DEA have promised to open up the sourcing of federally-approved research cannabis.

DEA 52
article thumbnail

Awakn Life Sciences Appoints Addiction Expert Prof. David Nutt as Chief Research Officer

Cannabis Law Report

Nutt Will Drive Progression of a Pipeline of New Psychedelic Medicines, Helping to Define a Clear Development Pathway to Treat Addiction Through Psychedelic Medicines. David Nutt, has joined its executive team as Chief Research Officer. Toronto, Ontario–(Newsfile Corp. June 24, 2021) – Awakn Life Sciences Corp.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Using Cannabis for ALS: Benefits, Research and Best Strains

Greencamp

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94
article thumbnail

Will Newly Developing Drug Breathalyzers Replace Other Forms of Testing?

Cannabis Law Report

She was the Presiding Judge 2009 and 2010 and the co-founder of the Denver County Court Sobriety Court. She is currently a law school professor teaching Marijuana and the Law at California Western School of Law and researcher under a contract with NHTSA and NORC on the topic of the prosecution of drugged driving cases.

article thumbnail

Are Cannabis Users 22% More Likely to Need Emergency Care?

Veriheal

Researchers wanted to evaluate the potential association between cannabis use and respiratory-related emergency room visits and hospitalizations. The population-based cohort study used data from the Ontario portion of the 2009-2010 and 2011-2012 Canada Community Health Survey (CCHS). Cannabis Consumers at the Hospital .

article thumbnail

Husch Blackwell Launches Psychedelics and Emerging Therapies Practice Group

Cannabis Law Report

Husch Blackwell has launched its Psychedelics and Emerging Therapie s team, an interdisciplinary, cross-office group of lawyers capable of addressing the challenges faced by innovators that seek to research, develop and commercialize novel therapies based on psychedelic drugs. Steve Levine. Marshall Custer.

Therapy 52
article thumbnail

Scientists Rank Most Dangerous Drugs

CannaMD

In 2010, a group of scientists from the United Kingdom’s Independent Scientific Committee on Drugs , including two invited specialists, met to rank the harm levels of 20 drugs. Their findings defied expectation, and now – over a decade later – their predictions appear to be more accurate than ever. Translation?